£795.00

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

The 2021-2026 World Outlook for Human Papillomavirus (HPV) Testing

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 52 days · 52 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 26 July 2026 07 August 2026 20 August 2026 02 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 39 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 52 days • 1 price levels

Days at Price
52 days 0 13 26 39 52 £795 Days at Price

Price Analysis

Most common price: £795 (52 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 52 days

Description
This study covers the world outlook for human papillomavirus (HPV) testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for human papillomavirus (HPV) testing. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Product Specifications
Format
paperback
ASIN
B082JQ3D92
Category
Books > Subjects
Domain
Amazon UK
Release Date
13 February 2020
Listed Since
13 December 2019

Similar Products You Might Like

The 2026-2031 World Outlook for HPV and CMV Therapeutics
98% match

The 2026-2031 World Outlook for HPV and CMV Therapeutics

£885.00 03 Oct 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for HPV and CMV Therapeutics for US Zip Codes

£490.00 27 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India

£515.00 03 Oct 2026
The 2023-2028 Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing for US Zip Codes
96% match

The 2023-2028 Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing for US Zip Codes

£490.00 05 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in India
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in India

£515.00 23 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 25 Aug 2026
Human Papillomavirus and Related Diseases - Medical Guide
96% match

Human Papillomavirus and Related Diseases - Medical Guide

IntechOpen

£139.00 15 Sep 2026
The 2023-2028 World Outlook for Cervical Cancer Treatments
96% match

The 2023-2028 World Outlook for Cervical Cancer Treatments

£795.00 27 Aug 2026
High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis
96% match

High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis

LAP Lambert Academic Publishing

£48.00 27 Sep 2026
Human Papillomavirus and Related Diseases - Clinical Perspective
95% match

Human Papillomavirus and Related Diseases - Clinical Perspective

IntechOpen

£139.00 15 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in China
95% match

The 2023-2028 Outlook for Cervical Cancer Treatments in China

£495.00 23 Aug 2026
Detection of human papilloma virus genome in laryngeal carcinomas: By means of in situ DNA hybridization
95% match

Detection of human papilloma virus genome in laryngeal carcinomas: By means of in situ DNA hybridization

LAP Lambert Academic Publishing

£53.87 19 Sep 2026
The 2025-2030 World Outlook for Cervical Cancer Treatments
95% match

The 2025-2030 World Outlook for Cervical Cancer Treatments

Price unavailable
The 2023-2028 Outlook for Cervical Cancer Treatments for US Zip Codes
95% match

The 2023-2028 Outlook for Cervical Cancer Treatments for US Zip Codes

£490.00 26 Aug 2026